List of Coherus BioSciences patents

Patents where

Current Assignee

Name

Coherus BioSciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11400072 Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy	Patent 11400072 was granted and assigned to Coherus BioSciences on August, 2022 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11400072	August 2, 2022
‌ US Patent 11576971 Method of filling a container with no headspace	Patent 11576971 was granted and assigned to Coherus BioSciences on February, 2023 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11576971	February 14, 2023
‌ US Patent 11752225 Systems and methods for producing sterile injection devices	Patent 11752225 was granted and assigned to Coherus BioSciences on September, 2023 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11752225	September 12, 2023
‌ US Patent 10207000 Stable aqueous formulations of adalimumab	Patent 10207000 was granted and assigned to Coherus BioSciences on February, 2019 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10207000	February 19, 2019
‌ US Patent 11396540 Methods for making recombinant proteins		Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11396540	July 26, 2022
‌ US Patent 9302002 Etanercept formulations stabilized with combinations of sugars and polyols	Patent 9302002 was granted and assigned to Coherus BioSciences on April, 2016 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	9302002	April 5, 2016
‌ US Patent 10155039 Stable aqueous formulations of adalimumab	Patent 10155039 was granted and assigned to Coherus BioSciences on December, 2018 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10155039	December 18, 2018
‌ US Patent 11426446 Stable aqueous formulations of aflibercept	Patent 11426446 was granted and assigned to Coherus BioSciences on August, 2022 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11426446	August 30, 2022
‌ US Patent 9801942 Etanercept formulations stabilized with metal ions	Patent 9801942 was granted and assigned to Coherus BioSciences on October, 2017 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	9801942	October 31, 2017
‌ US Patent 9662396 Stable aqueous formulations of etanercept	Patent 9662396 was granted and assigned to Coherus BioSciences on May, 2017 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	9662396	May 30, 2017
‌ US Patent 9393305 Etanercept formulations stabilized with xylitol	Patent 9393305 was granted and assigned to Coherus BioSciences on July, 2016 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	9393305	July 19, 2016
‌ US Patent 10159733 Stable aqueous formulations of adalimumab	Patent 10159733 was granted and assigned to Coherus BioSciences on December, 2018 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10159733	December 25, 2018
‌ US Patent 10159732 Stable aqueous formulations of adalimumab	Patent 10159732 was granted and assigned to Coherus BioSciences on December, 2018 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10159732	December 25, 2018
‌ US Patent 9382317 Stable aqueous formulations of adalimumab	Patent 9382317 was granted and assigned to Coherus BioSciences on July, 2016 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	9382317	July 5, 2016
‌ US Patent 10195275 Stable aqueous formulations of adalimumab	Patent 10195275 was granted and assigned to Coherus BioSciences on February, 2019 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10195275	February 5, 2019
‌ US Patent 11071782 Method of filling a container with no headspace	Patent 11071782 was granted and assigned to Coherus BioSciences on July, 2021 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11071782	July 27, 2021
‌ US Patent 10716852 Stable aqueous formulations of adalimumab	Patent 10716852 was granted and assigned to Coherus BioSciences on July, 2020 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10716852	July 21, 2020
‌ US Patent 10293049 Etanercept formulations stabilized with amino acids	Patent 10293049 was granted and assigned to Coherus BioSciences on May, 2019 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10293049	May 21, 2019
‌ US Patent 10722579 Stable aqueous formulations of adalimumab		Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10722579	July 28, 2020
‌ US Patent 10716854 Stable aqueous formulations of adalimumab	Patent 10716854 was granted and assigned to Coherus BioSciences on July, 2020 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10716854	July 21, 2020
‌ US Patent 10947306 Correctly folded etanercept in high purity and excellent yield	Patent 10947306 was granted and assigned to Coherus BioSciences on March, 2021 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10947306	March 16, 2021
‌ US Patent 10954295 Correctly folded etanercept in high purity and excellent yield	Patent 10954295 was granted and assigned to Coherus BioSciences on March, 2021 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10954295	March 23, 2021
‌ US Patent 10485869 Etanercept formulations stabilized with meglumine	Patent 10485869 was granted and assigned to Coherus BioSciences on November, 2019 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10485869	November 26, 2019
‌ US Patent 10493151 Etanercept formulations stabilized with sodium chloride	Patent 10493151 was granted and assigned to Coherus BioSciences on December, 2019 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	10493151	December 3, 2019
‌ US Patent 11229702 High concentration formulations of adalimumab	Patent 11229702 was granted and assigned to Coherus BioSciences on January, 2022 by the United States Patent and Trademark Office.	Coherus BioSciences	Coherus BioSciences	United States Patent and Trademark Office	11229702	January 25, 2022

Results per page:

75 results

0 selected

75 results

0 selected